John Randolph
Family Medicine · Liberty, SCNPI 1689677882
Payments from drug & device makers
Across 314 payments — averaging $15.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$870
- GSK$775
- Novo Nordisk$540
- AstraZeneca$477
- Boehringer Ingelheim$279
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$267
- plus $2K from 25 others
What the payments were for
- Food & beverage$4,893100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 60 | $870 |
| GSK | 50 | $775 |
| Novo Nordisk | 35 | $540 |
| AstraZeneca | 32 | $477 |
| Boehringer Ingelheim | 18 | $279 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 17 | $267 |
| AbbVie(2 entities) | 12 | $211 |
| Amgen | 9 | $174 |
| Dexcom, Inc. | 9 | $155 |
| Exact Sciences | 10 | $152 |
| Pfizer | 10 | $146 |
| Novartis | 9 | $143 |
| Abbott | 6 | $135 |
| Bayer | 6 | $92 |
| Merck | 5 | $59 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $49 |
| Insmed, Inc. | 3 | $48 |
| Sanofi-aventis U.S. LLC | 3 | $45 |
| Esperion Therapeutics, Inc. | 2 | $32 |
| Shield Therapeutics Inc | 2 | $30 |
| Johnson & Johnson | 2 | $30 |
| Phathom Pharmaceuticals, Inc. | 2 | $29 |
| Medtronic | 1 | $24 |
| Astellas Pharma US Inc | 1 | $22 |
| Ironshore Pharmaceuticals Inc. | 1 | $21 |
| Cranial Technologies, Inc | 1 | $18 |
| Daiichi Sankyo Inc. | 1 | $16 |
| Shire North American Group Inc | 1 | $15 |
| Eisai Inc. | 1 | $15 |
| Adlon Therapeutics L.p. | 1 | $13 |
| Supernus Pharmaceuticals, Inc. | 1 | $12 |
How this compares
$4,893 in reported general payments places this provider in the 85th percentile of 2,153 family medicine providers in South Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 168 | $171,660 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 161 | $148,250 |
| FarxigaDapagliflozin Propanediol | 121 | $120,826 |
| MounjaroTirzepatide | 60 | $114,663 |
| TrulicityDulaglutide | 53 | $79,975 |
| OzempicSemaglutide | 59 | $75,012 |
| XareltoRivaroxaban | 62 | $55,562 |
| RybelsusSemaglutide | 35 | $45,728 |
| EliquisApixaban | 51 | $40,869 |
| LinzessLinaclotide | 27 | $26,626 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 21 | $21,580 |
| MyrbetriqMirabegron | 27 | $16,096 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 12 | $14,398 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 26 | $13,795 |
| JanuviaSitagliptin Phosphate | 18 | $13,197 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $870 | $194,638113 claims |
| Boehringer IngelheimJardiance, Spiriva Respimat, Combivent Respimat | $279 | $185,566195 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $775 | $160,510190 claims |
| AstraZenecaFarxiga, Brilinta, Symbicort | $477 | $133,951159 claims |
| Novo NordiskOzempic, Rybelsus | $540 | $120,74094 claims |
| Johnson & JohnsonXarelto | $30 | $55,56262 claims |
| PfizerEliquis | $146 | $40,86951 claims |
| AbbVieLinzess | $211 | $26,62627 claims |
| Astellas Pharma US IncMyrbetriq | $22 | $16,09627 claims |
| MerckJanuvia | $59 | $13,19718 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,153 family medicine providers in South Carolina.
Other family medicine in Liberty
- Cayce TangemanGoose Creek$8.4M
- Jeremy AckermannMoncks Corner$7.6M
- Kelly MoralesNorth Charleston$6.5M
- William ByarsGreer$4.8M
- James FranklinGreenville$3.5M
- Stephen GrubbLittle River$3.4M
- Jeffrey HarrisGreenville$3.4M
- Shannon ConradN Charleston$3.3M
- Tom ChristensenLittle River$3.1M
- Edward NewtonCharleston$3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.